Nicotinamide pre-treatment ameliorates NAD(H) hyperoxidation and improves neuronal function after severe hypoxia

Area of Science:

• Neuroscience
• Biochemistry
• Cellular Metabolism

Background:

• Prolonged hypoxia causes irreversible neuronal damage and metabolic dysfunction.
• Reoxygenation after hypoxia leads to NADH hyperoxidation, impairing neuronal function.
• Nicotinamide adenine dinucleotide (NAD(+)) recycling is critical for neuronal energy metabolism.

Purpose of the Study:

• To investigate if nicotinamide or PARP-1 inhibition can mitigate neuronal dysfunction after severe hypoxia.
• To assess the impact of these interventions on NAD(+) levels and NADH hyperoxidation.
• To evaluate the recovery of neuronal function and ATP content.

Main Methods:

• Utilized hippocampal slices subjected to severe, prolonged hypoxia followed by reoxygenation.
• Administered nicotinamide (5mM) or PJ-34 (PARP-1 inhibitor) prior to hypoxic insult.
• Measured NAD(+) and NADH levels, ATP content, and neuronal field excitatory post-synaptic potential (fEPSP).

Main Results:

• Nicotinamide treatment increased total NAD(H) content, improved neuronal recovery, enhanced ATP levels, and prevented NADH hyperoxidation.
• PJ-34 treatment also improved neuronal recovery, NADH reduction, and ATP content.
• Both treatments were effective when administered prior to hypoxia, but not during or after.

Conclusions:

• Pre-treatment with nicotinamide or PJ-34 protects hippocampal neurons against severe hypoxic injury.
• Restoring NAD(+) levels and preventing NADH hyperoxidation are key mechanisms for neuroprotection.
• Therapeutic window for these interventions is critical, requiring administration before hypoxic insult.